Download PDF
Semin Thromb Hemost 2011; 37(8): 903-907
DOI: 10.1055/s-0031-1297369
© Thieme Medical Publishers

Obesity and Venous Thrombosis: A Review

Margaret A. Allman-Farinelli1
  • 1Department of Nutrition and Dietetics, School of Molecular Bioscience, University of Sydney, NSW, Australia
Further Information

Publication History

Publication Date:
23 December 2011 (online)

    Permissions and Reprints

ABSTRACT

The world is experiencing an obesity pandemic, with rates of obesity rising for more than two decades. Obesity is defined as a body mass index (BMI) of 30 kg/m2 or greater. Of particular concern are the risks that millions of obese people are likely to develop chronic diseases and at earlier ages than their parents might have. The risk of venous thrombosis increases with obesity, so that the incidence of this pathology is also expected to rise significantly. There is remarkable and consistent evidence from a systematic review, as well as cohort and case–control studies that obesity might predispose to venous thromboembolism (VTE). The risk appears to be at least double that for normal weight subjects (BMI 20 to 24.9 kg/m2). Plausible mechanisms exist to explain this relationship, including the physical effects of body fat limiting venous return and a proinflammatory, prothrombotic, and hypofibrinolytic milieu. Loss of body weight has been shown to reduce the concentrations of coagulation factors and plasminogen activator inhibitor-1 toward the normal range. Whether weight loss would prevent secondary occurrence of VTE in the absence of anticoagulant therapy could not be discerned from this literature search.

KEYWORDS

Obesity - thrombosis - venous thromboembolism

REFERENCES

  • 1 Nejat E J, Polotsky A J, Pal L. Predictors of chronic disease at midlife and beyond—the health risks of obesity.  Maturitas. 2010;  65 (2) 106-111
    Google Scholar
  • 2 Allman-Farinelli M A, Chey T, Bauman A E, Gill T, James W P. Age, period and birth cohort effects on prevalence of overweight and obesity in Australian adults from 1990 to 2000.  Eur J Clin Nutr. 2008;  62 (7) 898-907
    Google Scholar
  • 3 van Dam R M, Willett W C, Manson J E, Hu F B. The relationship between overweight in adolescence and premature death in women.  Ann Intern Med. 2006;  145 (2) 91-97
    Google Scholar
  • 4 Aitken R J, Allman-Farinelli M A, King L A, Bauman A. Current and future costs of cancer, heart disease and stroke attributable to obesity in Australia—a comparison of two birth cohorts.  Asia Pac J Clin Nutr. 2009;  18 63-70
    Google Scholar
  • 5 Allman-Farinelli M A, Aitken R J, King L A, Bauman A E. Osteoarthritis—the forgotten obesity-related epidemic with worse to come.  Med J Aust. 2008;  188 (5) 317
    Google Scholar
  • 6 Levin P D, Weissman C. Obesity, metabolic syndrome, and the surgical patient.  Med Clin North Am. 2009;  93 (5) 1049-1063
    Google Scholar
  • 7 Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population.  J Intern Med. 1992;  232 (2) 155-160
    Google Scholar
  • 8 Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen P W. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.  Circulation. 2008;  117 (1) 93-102
    Google Scholar
  • 9 Di Minno G, Mannucci P M, Tufano A First Ambulatory Screening On Thromboembolism (fast) Study Group et al. The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism.  J Thromb Haemost. 2005;  3 (7) 1459-1466 [Multicenter Study]
    Google Scholar
  • 10 Samama M M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Archives of Internal Medicine. [Research Support, Non-U.S. Govt].  2000 Dec 11–25;160(22):3415–20
    Google Scholar
  • 11 Cushman M. Epidemiology and risk factors for venous thrombosis.  Semin Hematol. 2007;  44 (2) 62-69
    Google Scholar
  • 12 Hansson P O, Eriksson H, Welin L, Svärdsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”.  Arch Intern Med. 1999;  159 (16) 1886-1890
    Google Scholar
  • 13 Romualdi E, Squizzato A, Ageno W. Abdominal obesity and the risk of recurrent deep vein thrombosis.  Thromb Res. 2007;  119 (6) 687-690
    Google Scholar
  • 14 Eichinger S, Hron G, Bialonczyk C et al.. Overweight, obesity, and the risk of recurrent venous thromboembolism.  Arch Intern Med. 2008;  168 (15) 1678-1683
    Google Scholar
  • 15 Ageno W, Piantanida E, Dentali F et al.. Body mass index is associated with the development of the post-thrombotic syndrome.  Thromb Haemost. 2003;  89 (2) 305-309
    Google Scholar
  • 16 Darvall K A, Sam R C, Silverman S H, Bradbury A W, Adam D J. Obesity and thrombosis.  Eur J Vasc Endovasc Surg. 2007;  33 (2) 223-233 [Review]
    Google Scholar
  • 17 Van Guilder G P, Hoetzer G L, Greiner J J, Stauffer B L, DeSouza C A. Metabolic syndrome and endothelial fibrinolytic capacity in obese adults.  Am J Physiol Regul Integr Comp Physiol. 2008;  294 (1) R39-R44
    Google Scholar
  • 18 Dellas C, Schäfer K, Rohm I et al.. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity.  Thromb Haemost. 2008;  100 (6) 1123-1129
    Google Scholar
  • 19 Chu N F, Spiegelman D, Hotamisligil G S, Rifai N, Stampfer M, Rimm E B. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men.  Atherosclerosis. 2001;  157 (2) 495-503
    Google Scholar
  • 20 Singh P, Peterson T E, Barber K R et al.. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells.  Biochem Biophys Res Commun. 2010;  392 (1) 47-52
    Google Scholar
  • 21 Juhan-Vague I, Alessi M C. Regulation of fibrinolysis in the development of atherothrombosis: role of adipose tissue.  Thromb Haemost. 1999;  82 (2) 832-836 [Review]
    Google Scholar
  • 22 Rosito G A, D'Agostino R B, Massaro J et al.. Association between obesity and a prothrombotic state: the Framingham Offspring Study.  Thromb Haemost. 2004;  91 (4) 683-689
    Google Scholar
  • 23 Alessi M C, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences.  Arterioscler Thromb Vasc Biol. 2006;  26 2200-2207
    Google Scholar
  • 24 Steffen L M, Cushman M, Peacock J M et al.. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.  J Thromb Haemost. 2009;  7 (5) 746-751
    Google Scholar
  • 25 Reiner A P, Siscovick D S, Rosendaal F R. Hemostatic risk factors and arterial thrombotic disease.  Thromb Haemost. 2001;  85 (4) 584-595
    Google Scholar
  • 26 Folsom A R, Qamhieh H T, Wing R R et al.. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.  Arterioscler Thromb. 1993;  13 (2) 162-169
    Google Scholar
  • 27 Marckmann P, Toubro S, Astrup A. Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects.  Eur J Clin Nutr. 1998;  52 (5) 329-333
    Google Scholar
  • 28 Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A. Weight change and blood coagulability and fibrinolysis in healthy obese women.  Int J Obes Relat Metab Disord. 2001;  25 (2) 212-218
    Google Scholar
  • 29 Tsai A W, Cushman M, Rosamond W D, Heckbert S R, Polak J F, Folsom A R. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.  Arch Intern Med. 2002;  162 (10) 1182-1189
    Google Scholar
  • 30 Ay C, Tengler T, Vormittag R et al.. Venous thromboembolism—a manifestation of the metabolic syndrome.  Haematologica. 2007;  92 (3) 374-380
    Google Scholar
  • 31 Lemkes B A, Hermanides J, Devries J H, Holleman F, Meijers JCM, Hoekstra JBL. Hyperglycemia: a prothrombotic factor?.  J Thromb Haemost. 2010;  8 (8) 1663-1669
    Google Scholar
  • 32 Lindqvist P G, Epstein E, Olsson H. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study.  Br J Haematol. 2009;  144 (2) 234-240
    Google Scholar
  • 33 van Stralen K J, Doggen CJM, Lumley T et al.. The relationship between exercise and risk of venous thrombosis in elderly people.  J Am Geriatr Soc. 2008;  56 (3) 517-522
    Google Scholar
  • 34 Van Guilder G P, Hoetzer G L, Smith D T et al.. Endothelial t-P`A release is impaired in overweight and obese adults but can be improved with regular aerobic exercise.  Am J Physiol Endocrinol Metab. 2005;  289 (5) E807-E813
    Google Scholar
  • 35 Aguilera C M, Ramírez-Tortosa M C, Mesa M D, Gil A. [Protective effect of monounsaturated and polyunsaturated fatty acids on the development of cardiovascular disease].  Nutr Hosp. 2001;  16 (3) 78-91
    Google Scholar
  • 36 Brand-Miller J, Dickinson S, Barclay A, Allman-Farinelli M. Glycemic index, glycemic load, and thrombogenesis.  Semin Thromb Hemost. 2009;  35 (1) 111-118
    Google Scholar
  • 37 Lutsey P L, Steffen L M, Virnig B A, Folsom A R. Diet and incident venous thromboembolism: the Iowa Women's Health Study.  Am Heart J. 2009;  157 (6) 1081-1087
    Google Scholar
  • 38 Steffen L M, Folsom A R, Cushman M, Jacobs Jr D R, Rosamond W D. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.  Circulation. 2007;  115 (2) 188-195
    Google Scholar

Margaret A. Allman-FarinelliPh.D. M.Phil.P.H. 

Associate Professor in Nutrition and Dietetics, School of Molecular Bioscience

University of Sydney, NSW 2006, Australia

Email: margaret.allmanfarinelli@sydney.edu.au

      >